BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 38469097)

  • 1. Molecular Pathogenesis of Central and Peripheral Nervous System Complications in Anderson-Fabry Disease.
    Tuttolomondo A; Baglio I; Riolo R; Todaro F; Parrinello G; Miceli S; Simonetta I
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for Fabry disease in a series of Parkinson's disease patients and literature review.
    Perillo S; Palmieri GR; Del Moral MO; De Michele G; Giglio A; Cuomo N; Pane C; Bauer P; De Michele G; De Rosa A
    Neurol Sci; 2023 Apr; 44(4):1235-1241. PubMed ID: 36547780
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Breyer M; Grüner J; Klein A; Finke L; Klug K; Sauer M; Üçeyler N
    Mol Genet Metab Rep; 2024 Mar; 38():101029. PubMed ID: 38469097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants of unknown significance in alpha-galactosidase A: Cellular delineation from Fabry disease.
    Klein A; Klug K; Breyer M; Grüner J; Medala VK; Nordbeck P; Wanner C; Klopocki E; Üçeyler N
    J Inherit Metab Dis; 2024 Apr; ():. PubMed ID: 38618884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of Fabry disease among 1009 unrelated patients with hypertrophic cardiomyopathy: a Russian nationwide screening program using NGS technology.
    Savostyanov K; Pushkov A; Zhanin I; Mazanova N; Trufanov S; Pakhomov A; Alexeeva A; Sladkov D; Asanov A; Fisenko A
    Orphanet J Rare Dis; 2022 May; 17(1):199. PubMed ID: 35578305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated interleukin-8 expression by skin fibroblasts as a potential contributor to pain in women with Fabry disease.
    Hofmann L; Grüner J; Klug K; Breyer M; Klein T; Hochheimer V; Wagenhäuser L; Wischmeyer E; Üçeyler N
    PLoS One; 2024; 19(4):e0300687. PubMed ID: 38593151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c.376A>G, (p.Ser126Gly) Alpha-Galactosidase A mutation induces ER stress, unfolded protein response and reduced enzyme trafficking to lysosome: Possible relevance in the pathogenesis of late-onset forms of Fabry Disease.
    Riillo C; Bonapace G; Moricca MT; Sestito S; Salatino A; Concolino D
    Mol Genet Metab; 2023 Nov; 140(3):107700. PubMed ID: 37774431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of GLA-knockout human embryonic stem cell lines to model peripheral neuropathy in Fabry disease.
    Kaneski CR; Hanover JA; Schueler Hoffman UH
    Mol Genet Metab Rep; 2022 Dec; 33():100914. PubMed ID: 36092250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-chromosomal inactivation patterns in women with Fabry disease.
    Wagenhäuser L; Rickert V; Sommer C; Wanner C; Nordbeck P; Rost S; Üçeyler N
    Mol Genet Genomic Med; 2022 Sep; 10(9):e2029. PubMed ID: 35971858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Globotriaosylceramide in Physiology and Pathology.
    Celi AB; Goldstein J; Rosato-Siri MV; Pinto A
    Front Mol Biosci; 2022; 9():813637. PubMed ID: 35372499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of the induced pluripotent stem cell line UKWNLi005-A derived from a patient with the GLA mutation c.376A > G of unknown pathogenicity in Fabry disease.
    Breyer M; Klein T; Klug K; Klopocki E; Üçeyler N
    Stem Cell Res; 2022 May; 61():102747. PubMed ID: 35325818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene variants of unknown significance in Fabry disease: Clinical characteristics of c.376A>G (p.Ser126Gly).
    Lau K; Üçeyler N; Cairns T; Lorenz L; Sommer C; Schindehütte M; Amann K; Wanner C; Nordbeck P
    Mol Genet Genomic Med; 2022 May; 10(5):e1912. PubMed ID: 35212486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chaperone Therapy in Fabry Disease.
    Weidemann F; Jovanovic A; Herrmann K; Vardarli I
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163813
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.